Previous studies have provided evidence that utilizing the positive surface expression of PD-1 enables the identification of tumor-specific T cells in multiple malignancies, and PD-1+ CD8+ T cells could also be detected in peripheral blood (33–35). The gene discussed is CD8A; the disease is neoplasm.